85 related articles for article (PubMed ID: 17257075)
21. A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
Tsuruta Y; Pereboeva L; Breidenbach M; Rein DT; Wang M; Alvarez RD; Siegal GP; Dent P; Fisher PB; Curiel DT
Clin Cancer Res; 2008 Jun; 14(11):3582-8. PubMed ID: 18519792
[TBL] [Abstract][Full Text] [Related]
22. Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment.
Davydova J; Le LP; Gavrikova T; Wang M; Krasnykh V; Yamamoto M
Cancer Res; 2004 Jun; 64(12):4319-27. PubMed ID: 15205347
[TBL] [Abstract][Full Text] [Related]
23. Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.
Lee CT; Park KH; Yanagisawa K; Adachi Y; Ohm JE; Nadaf S; Dikov MM; Curiel DT; Carbone DP
Cancer Res; 2004 Sep; 64(18):6660-5. PubMed ID: 15374981
[TBL] [Abstract][Full Text] [Related]
24. Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death.
Abou El Hassan MA; van der Meulen-Muileman I; Abbas S; Kruyt FA
J Virol; 2004 Nov; 78(22):12243-51. PubMed ID: 15507611
[TBL] [Abstract][Full Text] [Related]
25. Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy.
Oosterhoff D; van Beusechem VW
J Exp Ther Oncol; 2004 Apr; 4(1):37-57. PubMed ID: 15255291
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
[TBL] [Abstract][Full Text] [Related]
27. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
28. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
van Beusechem VW; van den Doel PB; Grill J; Pinedo HM; Gerritsen WR
Cancer Res; 2002 Nov; 62(21):6165-71. PubMed ID: 12414643
[TBL] [Abstract][Full Text] [Related]
29. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
30. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
31. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.
Wang G; Li G; Liu H; Yang C; Yang X; Jin J; Liu X; Qian Q; Qian W
J Gene Med; 2009 Jun; 11(6):477-85. PubMed ID: 19340843
[TBL] [Abstract][Full Text] [Related]
32. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
Oosterhoff D; Pinedo HM; Witlox MA; Carette JE; Gerritsen WR; van Beusechem VW
Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
[TBL] [Abstract][Full Text] [Related]
33. An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism.
Glasgow JN; Kremer EJ; Hemminki A; Siegal GP; Douglas JT; Curiel DT
Virology; 2004 Jun; 324(1):103-16. PubMed ID: 15183058
[TBL] [Abstract][Full Text] [Related]
34. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)].
Zhao ZP; Xia XZ; Hu RL; Xie ZJ; Yan F; Huang G; Yang ST
Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles.
Li H; Haviv YS; Derdeyn CA; Lam J; Coolidge C; Hunter E; Curiel DT; Blackwell JL
Hum Gene Ther; 2001 Dec; 12(18):2155-65. PubMed ID: 11779400
[TBL] [Abstract][Full Text] [Related]
36. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.
Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO
Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236
[TBL] [Abstract][Full Text] [Related]
37. A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
Delgado-Enciso I; Cervantes-García D; Martínez-Dávila IA; Ortiz-López R; Alemany-Bonastre R; Silva-Platas CI; Lugo-Trampe A; Barrera-Saldaña HA; Galván-Salazar HR; Coronel-Tene CG; Sánchez-Santillán CF; Rojas-Martínez A
J Gene Med; 2007 Oct; 9(10):852-61. PubMed ID: 17729237
[TBL] [Abstract][Full Text] [Related]
38. Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication.
Zhang H; Takayama K; Zhang L; Uchino J; Harada A; Harada T; Hisasue J; Nakagaki N; Zhou C; Nakanishi Y
Cancer Gene Ther; 2009 May; 16(5):415-22. PubMed ID: 19148207
[TBL] [Abstract][Full Text] [Related]
39. Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.
Stoff-Khalili MA; Rivera AA; Le LP; Stoff A; Everts M; Contreras JL; Chen D; Teng L; Rots MG; Haisma HJ; Rocconi RP; Bauerschmitz GJ; Rein DT; Yamamoto M; Siegal GP; Dall P; Michael Mathis J; Curiel DT
Cancer Gene Ther; 2006 Jun; 13(6):606-18. PubMed ID: 16410819
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
